Article Versions Notes

Skrzypiec-Spring M, Sapa-Wojciechowska A, Haczkiewicz-Leśniak K, Piasecki T, Kwiatkowska J, Podhorska-Okołów M, Szeląg A. HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation. Biomolecules. 2021; 11(10):1415. https://doi.org/10.3390/biom11101415

Skrzypiec-Spring, Monika, Agnieszka Sapa-Wojciechowska, Katarzyna Haczkiewicz-Leśniak, Tomasz Piasecki, Joanna Kwiatkowska, Marzenna Podhorska-Okołów, and Adam Szeląg. 2021. "HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation" Biomolecules 11, no. 10: 1415. https://doi.org/10.3390/biom11101415

Skrzypiec-Spring, M., Sapa-Wojciechowska, A., Haczkiewicz-Leśniak, K., Piasecki, T., Kwiatkowska, J., Podhorska-Okołów, M., & Szeląg, A. (2021). HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation. Biomolecules, 11(10), 1415. https://doi.org/10.3390/biom11101415